Clinical Research in Cardiology

, Volume 100, Issue 3, pp 209–215 | Cite as

Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome

  • Kerstin Kurz
  • Evangelos Giannitsis
  • Maike Becker
  • Georg Hess
  • Dietmar Zdunek
  • Hugo A. Katus
Original Paper



We sought to determine the performance of the new high sensitivity cardiac troponin T assay (TnThs) for early diagnosis of myocardial infarction in patients with suspected acute coronary syndrome (ACS) and compare it with the fourth generation cTnT assay, myoglobin and heart-type fatty acid binding protein (h-FABP).


Ninety-four patients with diagnosis of suspected ACS without ST-segment elevation admitted to our chest pain unit were included. Patients were divided according to time from onset of symptoms to presentation into an early presenter group (<4 h) and a late presenter group (≥4 h). A median of six samples (range 2–8) were available per patient. The diagnostic performance of TnThs was assessed using ROC analysis. Areas under the curve (AUC) of baseline and follow-up results of TnThs, cTnT, myoglobin, and h-FABP were compared using c statistics.


The TnThs assay allows an excellent prediction of non-ST-segment elevation myocardial infarction (non-STEMI) at presentation, particularly among late presenters. A follow-up sample improves diagnostic performance in a time-dependent manner. The AUC of TnThs was superior to cTnT at all time points. The performance of TnThs was at least as good as myoglobin and h-FABP at presentation and during follow-up.


A baseline sample of TnThs allows an earlier prediction of non-STEMI than the less sensitive and precise fourth generation cTnT assay. Probably, this excellent performance of TnThs at baseline and follow-up could obviate the need for other early markers of necrosis in future.


High sensitive troponin T Cardiac necrosis Early detection Myoglobin h-FABP 



The investigations were supported by Roche Diagnostics, Germany providing assays for TnThs. EG has received research grants for clinical trials from Roche Diagnostics & MSD Germany. He is consultant to Roche Diagnostics and has received speakers honoraria from Roche Diagnostics and Mitsubishi Chemicals. HAK has developed the cTnT assay and holds a patent jointly with Roche Diagnostics. He has received grants and research support from several companies, and has received honoraria for lectures from Roche Diagnostics. Dr. D. Zdunek and Prof. G. Hess are employees of Roche Diagnostics responsible for the preclinical testing of TnThs.


  1. 1.
    Thygesen K, Alpert JS, White HD, On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of Myocardial Infarction (2007) Universal definition of myocardial infarction. J Am Coll Cardiol 50:2173–2195CrossRefPubMedGoogle Scholar
  2. 2.
    Hermens WT (1998) Mechanisms of protein release from injured heart muscle. Dev Cardiovasc Med 205:85–98Google Scholar
  3. 3.
    Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB et al (2007) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53:552–574CrossRefPubMedGoogle Scholar
  4. 4.
    Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, Bergmann A, Potocki M, Noveanu M, Breidthardt T, Christ A, Boldanova T, Merki R, Schaub N, Bingisser R, Christ M, Mueller C (2009) Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 54:60–68CrossRefPubMedGoogle Scholar
  5. 5.
    Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ (1992) Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 116:155–162CrossRefPubMedGoogle Scholar
  6. 6.
    Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361:858–867CrossRefPubMedGoogle Scholar
  7. 7.
    Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA (2010) Analytical validation of a high sensitivity cardiac troponin T assay. Clin Chem 56:254–261CrossRefPubMedGoogle Scholar
  8. 8.
    Robers M, Van der Hulst FF, Fischer MA, Roos W, Salud CE, Eisenwiener HG et al (1998) Development of a rapid microparticle-enhanced turbidimetric immunoassay for plasma fatty acid-binding protein, an early marker of acute myocardial infarction. Clin Chem 44:1564–1567PubMedGoogle Scholar
  9. 9.
    Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA (2010) High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 56:642–650CrossRefPubMedGoogle Scholar
  10. 10.
    Brogan GX Jr, Friedman S, McCuskey C, Cooling DS, Berrutti L, Thode HC Jr, Bock JL (1994) Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med 24:665–671CrossRefPubMedGoogle Scholar
  11. 11.
    Ohman EM, Casey C, Bengtson JR, Pryor D, Tormey W, Horgan JH (1990) Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation. Br Heart J 63:335–338CrossRefPubMedGoogle Scholar
  12. 12.
    Maisel AS, Templin K, Love M, Clopton P (2000) A prospective study of an algorithm using cardiac troponin I and myoglobin as adjuncts in the diagnosis of acute myocardial infarction and intermediate coronary syndromes in a veteran’s hospital. Clin Cardiol 23:915–920CrossRefPubMedGoogle Scholar
  13. 13.
    McCord J, Nowak RM, McCullough PA, Foreback C, Borzak S, Tokarski G (2001) Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation 104:1483–1488CrossRefPubMedGoogle Scholar
  14. 14.
    Ng SM, Krishnaswamy P, Morissey R, Clopton P, Fitzgerald R, Maisel AS (2001) Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol 88:611–617CrossRefPubMedGoogle Scholar
  15. 15.
    Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AH, Jaffe AS (2005) Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 51:2198–2200CrossRefPubMedGoogle Scholar
  16. 16.
    Eggers KM, Oldgren J, Nordenskjöld A, Lindahl B (2004) Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 148:574–581CrossRefPubMedGoogle Scholar
  17. 17.
    Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM (2008) Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 54:723–728CrossRefPubMedGoogle Scholar
  18. 18.
    Gaze DC (2010) High-sensitive cardiac troponin assays: application for prime-time use. Biomark Med 4:341–343CrossRefPubMedGoogle Scholar
  19. 19.
    Lippi G, Montagnana M, Guidi GC (2009) The clinical dilemma of positive results of high-sensitive troponin assays. Am J Cardiol 103:1332CrossRefPubMedGoogle Scholar
  20. 20.
    Neizel M, Steen H, Korosoglou G, Lossnitzer D, Lehrke S, Ivandic BT, Katus HA, Giannitsis E (2009) Minor troponin T elevation in patients 6 months after myocardial infarction: an observational study. Clin Res Cardiol 98:297–304CrossRefPubMedGoogle Scholar
  21. 21.
    Wu AHB, Lu QA, Todd J, Moecks J, Wians F (2009) Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 55:52–58CrossRefPubMedGoogle Scholar
  22. 22.
    Seino Y, Tomita Y, Takano T, Ohbayashi K, Tokyo Rapid-Test Office Cardiologists (Tokyo-ROC) Study (2004) Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. Circ J 68:144–148CrossRefPubMedGoogle Scholar
  23. 23.
    Valle HA, Riesgo LG, Bel MS, Gonzalo FE, Sanchez MS, Oliva LI (2008) Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome. Eur J Emerg Med 15:140–144CrossRefPubMedGoogle Scholar
  24. 24.
    Ghani F, Wu AH, Graff L, Petry C, Armstrong G, Prigent F, Brown M (2000) Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 46:718–719PubMedGoogle Scholar
  25. 25.
    Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Fröhlich M, Sinning CR, Eleftheriadis MS, Wild PS, Schnabel RB, Lubos E, Jachmann N, Genth-Zotz S, Post F, Nicaud V, Tiret L, Lackner KJ, Münzel TF, Blankenberg S (2009) Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 361:868–877CrossRefPubMedGoogle Scholar
  26. 26.
    Ilva T, Lund J, Porela P, Mustonen H, Voipio-Pulkki LM, Eriksson S, Pettersson K, Tanner P, Pulkki K (2009) Early markers of myocardial injury: cTnI is enough. Clin Chim Acta 400:82–85CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Kerstin Kurz
    • 1
  • Evangelos Giannitsis
    • 1
  • Maike Becker
    • 1
  • Georg Hess
    • 2
  • Dietmar Zdunek
    • 2
  • Hugo A. Katus
    • 1
  1. 1.Medizinische Klinik, Abteilung für Innere Medizin IIIUniversitätsklinikum HeidelbergHeidelbergGermany
  2. 2.Roche Diagnostics GmbHPenzbergGermany

Personalised recommendations